IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc., developer of the first rechargeable Sacral Neuromodulation (r-SNM™) system for the treatment of urinary and fecal dysfunction, ...
Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Axonics (NASDAQ:AXNX) in the last three months. Summarizing their recent assessments, the table ...
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel ...
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Castle Biosciences (CSTL – Research Report), Axonics Modulation Technologies (AXNX – Research Report) and ...
Medical device giant Boston Scientific announced a $3.7 billion deal on Monday to augment its urology portfolio. The company is acquiring Axonics, a maker of neurostimulation devices that treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback